Allspring Global Investments Holdings LLC trimmed its stake in BlackRock Health Sciences Term Trust (NYSE:BMEZ – Free Report) by 16.9% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 295,591 shares of the company’s stock after selling 60,036 shares during the quarter. Allspring Global Investments Holdings LLC’s holdings in BlackRock Health Sciences Term Trust were worth $4,257,000 at the end of the most recent quarter.
A number of other institutional investors also recently made changes to their positions in the stock. Oppenheimer & Co. Inc. raised its holdings in shares of BlackRock Health Sciences Term Trust by 0.6% in the third quarter. Oppenheimer & Co. Inc. now owns 204,354 shares of the company’s stock worth $3,237,000 after acquiring an additional 1,153 shares during the last quarter. Brown Brothers Harriman & Co. acquired a new position in BlackRock Health Sciences Term Trust in the third quarter valued at $32,000. Dakota Wealth Management increased its stake in BlackRock Health Sciences Term Trust by 23.4% in the third quarter. Dakota Wealth Management now owns 22,509 shares of the company’s stock valued at $357,000 after purchasing an additional 4,267 shares during the last quarter. Brown Lisle Cummings Inc. increased its stake in BlackRock Health Sciences Term Trust by 17.0% in the fourth quarter. Brown Lisle Cummings Inc. now owns 42,711 shares of the company’s stock valued at $615,000 after purchasing an additional 6,198 shares during the last quarter. Finally, Stifel Financial Corp increased its stake in BlackRock Health Sciences Term Trust by 2.2% in the third quarter. Stifel Financial Corp now owns 414,346 shares of the company’s stock valued at $6,563,000 after purchasing an additional 8,843 shares during the last quarter.
BlackRock Health Sciences Term Trust Trading Up 0.8 %
BlackRock Health Sciences Term Trust stock opened at $16.08 on Friday. The stock has a fifty day moving average price of $15.56 and a 200 day moving average price of $15.67. BlackRock Health Sciences Term Trust has a 52 week low of $14.27 and a 52 week high of $16.75.
BlackRock Health Sciences Term Trust Dividend Announcement
BlackRock Health Sciences Term Trust Profile
BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.
Featured Stories
- Five stocks we like better than BlackRock Health Sciences Term Trust
- What is Forex and How Does it Work?
- Ray Dalio’s Bridgewater Loaded Up on These Stocks in Q4 2024
- Compound Interest and Why It Matters When Investing
- Walmart Faces Tariff Headwinds, Consumer Trends Remain Positive
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Tesla: 2 Reasons to Buy, 1 Reason to Run
Receive News & Ratings for BlackRock Health Sciences Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.